PCVX
Vaxcyte (PCVX)
$01
About Vaxcyte (PCVX)
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.
Details
Daily high
$53.39
Daily low
$50.82
Price at open
$50.82
52 Week High
$65.00
52 Week Low
$28.64
Market cap
7.7B
Dividend yield
0.00%
Volume
1.9M
Avg. volume
1.4M
P/E ratio
-7.61
Vaxcyte News
Details
Daily high
$53.39
Daily low
$50.82
Price at open
$50.82
52 Week High
$65.00
52 Week Low
$28.64
Market cap
7.7B
Dividend yield
0.00%
Volume
1.9M
Avg. volume
1.4M
P/E ratio
-7.61